Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2010
08/11/2010CN101801925A antiviral compounds
08/10/2010US7772394 Zaleplon synthesis
08/10/2010US7772249 Imidazo[1,2-b]pyridazine compound
08/10/2010US7772247 vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) receptor antagonists such as 1-(4-(2-(N-methoxy-N-methylcarbamoyl)thieno[3,2-b]pyridin-7yloxy)-3-fluorophenyl)-3-(2-phenylacetyl)thiourea, used as antiproliferative agents
08/10/2010US7772234 Bicyclic inhibitors of MEK and methods of use thereof
08/10/2010US7772231 such as cis-4-(4-(4-amino-3-(2-phenyl-1H-benzimidazol-6-yl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)cyclohexyl)-1-methylpiperazin-2-one, used as anticarcinogenic agents
08/10/2010US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes
08/10/2010US7772225 N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
08/10/2010US7772198 cycstic fibrosis transmembrane conductance regulators (CFTR); for treatment of cystic fibrosis, asthma or diarrhea
08/10/2010US7771695 Diels-Alder adduct of polyacene with dienophile; semiconductors, field effect transistors
08/10/2010CA2527375C Beta-strand mimetics and methods relating thereto
08/10/2010CA2488592C 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
08/10/2010CA2483159C Triazole derivatives as tachykinin receptor antagonists
08/10/2010CA2477967C Purine derivatives as kinase inhibitors
08/10/2010CA2471147C Nitric oxide donors for treatment of disease and injury
08/10/2010CA2451768C Peptoid compounds
08/10/2010CA2451605C Diamine derivatives
08/10/2010CA2440714C Pyrazolopyrimidines as therapeutic agents
08/05/2010WO2010088574A1 Azabenzimidazoles and related analogs as sirtuin modulators
08/05/2010WO2010088518A2 Heterocyclic modulators of gpr119 for treatment of disease
08/05/2010WO2010088368A2 Imidazopyrazines as protein kinase inhibitors
08/05/2010WO2010088050A2 Bicyclic pyrazolo-heterocycles
08/05/2010WO2010087762A1 2-aza-bicyclo[2.2.1]heptane compounds and uses thereof
08/05/2010WO2010087527A1 Ultraviolet absorbers, and pharmaceutical compositions and cosmetics containing pyrimidine compounds for uv protection
08/05/2010WO2010087515A1 Fused ring compound and use thereof
08/05/2010WO2010087471A1 Hydroxypyrazinecarboxamide derivatives
08/05/2010WO2010087467A1 Delta-5-desaturase inhibitors
08/05/2010WO2010087294A1 Triazolopyrimidine derivative or its salt, process for producing the same and pesticide containing the same
08/05/2010WO2010086089A1 Metal complexes
08/05/2010WO2010086040A1 Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
08/05/2010WO2010045303A3 Pyrrolidine, piperidine and piperazine derivatives and methods of use thereof
08/05/2010WO2010005480A3 Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
08/05/2010WO2009100872A8 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
08/05/2010US20100197912 Polymorphic and hydrate forms, salts and process for preparing 6-quinoline
08/05/2010US20100197911 Nitrogen-Containing Aromatic Derivatives
08/05/2010US20100197693 Novel benzenesulfonamides as calcium channel blockers
08/05/2010US20100197692 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
08/05/2010US20100197684 Substituted heterocyclic compounds
08/05/2010US20100197683 Fused ring compound and use thereof
08/05/2010US20100197682 Organic Compounds
08/05/2010US20100197678 Glucocorticoid Mimetics, Methods of Making Them, Pharmaceutical Compositions and Uses Thereof
08/05/2010US20100197668 1,2,3,4-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE AND 2,3,4,5-TETRAHYDROPYRROLO[1,2-a][1,4]-DIAZEPINE-7-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
08/05/2010US20100197667 Biphenyl compounds useful as muscarinic receptor antagonists
08/05/2010US20100197658 Pharmaceutical use of fused 1,2,4-triazoles
08/05/2010US20100197562 Functionally selective alpha2c adrenoreceptor agonists
08/05/2010US20100196357 Microrna modulators and method for identifying and using the same
08/05/2010US20100196321 Compounds
08/05/2010US20100196271 Cage-Like Bifunctional Chelators, Copper-64 Radiopharmaceuticals and PET Imaging Using the Same
08/05/2010CA2750710A1 Fused ring compound and use thereof
08/05/2010CA2749884A1 Bicyclic pyrazolo-heterocycles
08/04/2010EP2213674A1 Purification method of pemetrexed salts,sodium salts and disodium salts
08/04/2010EP2213673A1 Pyridone-substituted-dihydropyrazolopyrimidinone derivative
08/04/2010EP2213662A1 Azaindenofluorenedione derivative, organic electroluminescent device material, and organic electroluminescent device
08/04/2010EP2212936A1 Use of halogenated phthalocyanines
08/04/2010EP2212330A2 Novel compounds of reverse turn mimetics and the use thereof (3)
08/04/2010EP2212329A2 Novel compounds of reverse turn mimetics and the use thereof (1)
08/04/2010EP2212328A2 Novel compounds of reverse turn mimetics and the use thereof (2)
08/04/2010EP2212327A1 2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide crystalline form 1
08/04/2010EP2212326A1 2-anilinopurin-8-ones as inhibitors of ttk/mps1 for the treatment of proliferative disorders
08/04/2010EP2212297A1 Inhibitors of protein kinases
08/04/2010EP2212291A1 Heterocycle phenyl amide t-type calcium channel antagonists
08/04/2010EP1638947B1 Triazole derivatives as inhibitors of 11-beta hydroxysteroid dehydrogenase-1
08/04/2010EP1438015B1 Cosmetic and dermopharmaceutical compositions for skin prone to acne
08/04/2010CN101795711A chemical linkers and cleavable substrates and conjugates thereof
08/04/2010CN101792447A Process and device for preparing urotropine by using gas phase method
08/04/2010CN101103033B Triazolophthalazines as PDE2-inhibitors
08/03/2010US7767824 5,5-dibenzylimidazo[2,1-b]thiazol-6(5H)-one, useful as cognition activators in connection with treatments on memory disturbance, memory acquirement and retention disturbance, for example in Alzheimer's disease
08/03/2010US7767814 2-benzyl-3-[4a-(3-hydroxy-phenyl)-10a-methyl-3,4,4a,5,10,10a-hexahydro-1H-benzo[g]isoquinolin-2-yl]-propionic acid, used for prevention or treatment of gastrointestinal disorders, obesity, pain and reducing side effects associated with an opioid such as constipation, nausea and vomiting
08/03/2010US7767810 Macrocyclic modules comprising linked cyclic synthon units for use in the formation of selectively permeable membranes
08/03/2010US7767807 Use of phthalocyanines as marking substances for liquids
08/03/2010US7767706 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication
08/03/2010US7767689 Carboline derivatives useful in the treatment of cancer
08/03/2010US7767687 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors
08/03/2010US7767675 Imidazotriazines and imidazopyrimidines as kinase inhibitors
08/03/2010US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators
08/03/2010US7767659 Synthesis of naturally occurring ecteinascidins and related compounds
08/03/2010US7767193 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
08/03/2010CA2489158C Process for hydrogenating unactivated imines using ruthenium complexes as catalysts
08/03/2010CA2461426C Imidazo-pyrimidine derivatives as ligands for gaba receptors
07/2010
07/29/2010WO2010085820A2 Tricyclic compounds as antagonists of prostaglandin d2 receptors
07/29/2010WO2010085597A1 Macrocyclic compounds and their use as kinase inhibitors
07/29/2010WO2010084944A1 NOVEL PYRROLO[2,3-d]PYRIMIDINE COMPOUND
07/29/2010WO2010084438A1 Amino-heterocyclic compounds used as pde9 inhibitors
07/29/2010WO2010084425A1 New adenosine receptor ligands and uses thereof
07/29/2010WO2010083870A1 Novel heterocyclic compounds for use as metap-2 inhibitors
07/29/2010WO2010083645A1 PYRIMIDO[5,4-e][1,2,4]TRIAZINES AND USES THEREOF
07/29/2010WO2010083617A1 Pyrazolopyrimidines as protein kinase inhibitors
07/29/2010WO2010042925A3 Compositions and methods for treating alcohol use disorders, pain and other diseases
07/29/2010WO2010014930A3 Piperidine derivatives as jak3 inhibitors
07/29/2010US20100191475 Method for identification and functional characterization of agents which modulate ion channel activity
07/29/2010US20100190981 Processes for preparing jak inhibitors and related intermediate compounds
07/29/2010US20100190805 Preparation for the treatment of equine laminitis
07/29/2010US20100190804 Macrocyclic compounds and their use as kinase inhibitors
07/29/2010US20100190797 Crystalline polymophic forms of zopiclone, processes for their preparation and their pharmaceutical compositions
07/29/2010US20100190795 Betulin derived compounds useful as antiprotozoal agents
07/29/2010US20100190782 Compounds and methods of use
07/29/2010US20100190775 Pyrimidodiazepinone derivative
07/29/2010US20100190774 Inhibitors of c-met and uses thereof
07/29/2010US20100190773 Anti-Cytokine Heterocyclic Compounds
07/29/2010US20100190771 Amino-heterocyclic compounds
1 ... 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 ... 573